Breast Cancer
Estrogen receptor promoter methylation is an early marker for premalignant lesions
Published in Women's Health Weekly, February 23rd, 2006
"The function of ER-beta in mammary tissue is not completely understood. While early observations were often conflicting, more recent data suggest an important role as a tumor-suppressor gene," wrote A. Rody and colleagues, University of Frankfurt.
"A decrease of ER-beta expression has been observed in ductal carcinoma in situ and invasive carcinoma as compared with benign mammary epithelial cells. The loss of ER-beta resulted in abnormal...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer Prevention
Modifying eating habits may be more cancer-protective than adopting new diet pattern - Breast Cancer Screening
Excision is recommended for all stellate lesions detected by mammography - Hormone Replacement Therapy
Design flaws may have been source of adverse conclusions in Women's Health Initiative study - Osteoporosis Risk Factors
Bone loss decreased in women treated with milk basic protein supplement - Pregnancy Complications
Growing trend in prepregnancy obesity may lead to increased high-risk pregnancies - Abortion
Increased mental health problems are noted in young women who have had an abortion - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
